## Core Concept
Radionuclide imaging, also known as nuclear medicine, involves the use of small amounts of radioactive tracers to diagnose and determine the severity of or treat a variety of diseases, including many types of cancers, heart disease, gastrointestinal, endocrine, and bone disorders. For skeletal imaging, the goal is to visualize the bone structure and its metabolic activity.

## Why the Correct Answer is Right
Technetium-99m-methyl diphosphonate (Tc-99m MDP) is the most commonly used radiopharmaceutical for bone imaging. It accumulates in bone in proportion to osteoblastic activity, which makes it highly useful for detecting areas of altered bone metabolism, such as fractures, infections, and tumors. The mechanism involves the exchange of phosphate ions on the hydroxyapatite crystal surface of bone, with Tc-99m MDP binding to the calcium ions in bone, thereby providing a good image of bone structure and function.

## Why Each Wrong Option is Incorrect
- **Option A:** While certain positron-emitting isotopes like Fluorine-18 (F-18) are used in PET scans for various types of imaging, F-18 fluoride is specifically used for bone imaging but is less commonly used compared to Tc-99m MDP due to the higher cost and limited availability of PET scanners.
- **Option B:** This option seems to be a placeholder and does not specify a known radiopharmaceutical.
- **Option D:** Gallium-67 citrate is primarily used for soft tissue imaging, particularly for detecting infections and certain types of tumors, not for skeletal imaging.

## Clinical Pearl / High-Yield Fact
A key point to remember is that **Tc-99m MDP** is taken up by bone in areas of high osteoblastic activity, making it particularly useful for detecting metastatic bone disease, osteomyelitis, and fractures. Uptake is also seen in areas of bone repair, which can be a pitfall in interpretation.

## Correct Answer: C. Tc-99m MDP.